

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.74730773 |
| 2 | negative T cell selection (GO:0043383) | 7.43465326 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.27671633 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.96143752 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.96143752 |
| 6 | positive thymic T cell selection (GO:0045059) | 6.59667175 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.49687171 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.48179230 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.48179230 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.46948998 |
| 11 | thymic T cell selection (GO:0045061) | 6.12104368 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.04287037 |
| 13 | positive T cell selection (GO:0043368) | 5.98525322 |
| 14 | response to interleukin-15 (GO:0070672) | 5.98067526 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 5.87222612 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 5.76308117 |
| 17 | T cell selection (GO:0045058) | 5.69690148 |
| 18 | interferon-gamma production (GO:0032609) | 5.39523658 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.36949334 |
| 20 | regulation of T cell tolerance induction (GO:0002664) | 5.31811999 |
| 21 | leukocyte aggregation (GO:0070486) | 5.31129190 |
| 22 | T cell migration (GO:0072678) | 5.30836798 |
| 23 | T cell receptor signaling pathway (GO:0050852) | 5.03874885 |
| 24 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 4.89378997 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.73623795 |
| 26 | T cell costimulation (GO:0031295) | 4.73534795 |
| 27 | positive regulation of tolerance induction (GO:0002645) | 4.71580849 |
| 28 | lymphocyte costimulation (GO:0031294) | 4.70097772 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51597347 |
| 30 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.46232215 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 4.45967166 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38812943 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38812943 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.38812943 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38812943 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 4.38812943 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38812943 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.37494594 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.30208851 |
| 40 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.24148647 |
| 41 | tolerance induction (GO:0002507) | 4.22784913 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.21364916 |
| 43 | regulation of tolerance induction (GO:0002643) | 4.13216522 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.10620664 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.02620941 |
| 46 | positive regulation of isotype switching (GO:0045830) | 3.92376464 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 3.85148220 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.82045441 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.79980984 |
| 50 | mast cell activation (GO:0045576) | 3.77539589 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.77098631 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.74503263 |
| 53 | ribosomal small subunit assembly (GO:0000028) | 3.70996341 |
| 54 | detection of bacterium (GO:0016045) | 3.68722901 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.65168007 |
| 56 | regulation of response to interferon-gamma (GO:0060330) | 3.64389633 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64147840 |
| 58 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.62714022 |
| 59 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.62714022 |
| 60 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.60748726 |
| 61 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.60748726 |
| 62 | detection of other organism (GO:0098543) | 3.60187017 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60126184 |
| 64 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.59401923 |
| 65 | sequestering of actin monomers (GO:0042989) | 3.57164725 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.55132045 |
| 67 | T cell homeostasis (GO:0043029) | 3.54627023 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 3.54061517 |
| 69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.53836294 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51845963 |
| 71 | activated T cell proliferation (GO:0050798) | 3.51327940 |
| 72 | T cell differentiation (GO:0030217) | 3.50822600 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 3.48843998 |
| 74 | cellular extravasation (GO:0045123) | 3.47208259 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 3.46127973 |
| 76 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.44156810 |
| 77 | positive regulation of DNA recombination (GO:0045911) | 3.38648879 |
| 78 | positive regulation of granulocyte differentiation (GO:0030854) | 3.38564581 |
| 79 | B cell mediated immunity (GO:0019724) | 3.38030153 |
| 80 | positive regulation of humoral immune response (GO:0002922) | 3.38005916 |
| 81 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.37946222 |
| 82 | positive regulation of B cell mediated immunity (GO:0002714) | 3.37946222 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.37645296 |
| 84 | leukocyte cell-cell adhesion (GO:0007159) | 3.36778959 |
| 85 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.34929668 |
| 86 | alpha-beta T cell activation (GO:0046631) | 3.33425686 |
| 87 | positive regulation of immunoglobulin production (GO:0002639) | 3.27538170 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 3.27140212 |
| 89 | natural killer cell activation (GO:0030101) | 3.23846441 |
| 90 | T cell activation (GO:0042110) | 3.22027862 |
| 91 | alpha-beta T cell differentiation (GO:0046632) | 3.20623114 |
| 92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19118546 |
| 93 | response to type I interferon (GO:0034340) | 3.18759192 |
| 94 | respiratory burst (GO:0045730) | 3.18147826 |
| 95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.18026348 |
| 96 | response to host immune response (GO:0052572) | 3.15718070 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15718070 |
| 98 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.15284445 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15270035 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 3.14172310 |
| 101 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.13758098 |
| 102 | viral transcription (GO:0019083) | 3.13464714 |
| 103 | * regulation of isotype switching (GO:0045191) | 3.13230499 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 3.12951517 |
| 105 | response to muramyl dipeptide (GO:0032495) | 3.12320155 |
| 106 | negative regulation of innate immune response (GO:0045824) | 3.12166322 |
| 107 | cellular response to type I interferon (GO:0071357) | 3.11992733 |
| 108 | type I interferon signaling pathway (GO:0060337) | 3.11992733 |
| 109 | regulation of defense response to virus by virus (GO:0050690) | 3.10812619 |
| 110 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.09210585 |
| 111 | mast cell activation involved in immune response (GO:0002279) | 3.07773545 |
| 112 | mast cell degranulation (GO:0043303) | 3.07773545 |
| 113 | leukocyte degranulation (GO:0043299) | 3.07494365 |
| 114 | response to peptidoglycan (GO:0032494) | 3.06349863 |
| 115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05957318 |
| 116 | regulation of cell killing (GO:0031341) | 3.05757671 |
| 117 | lymphocyte homeostasis (GO:0002260) | 3.04595072 |
| 118 | lymphocyte migration (GO:0072676) | 3.03164310 |
| 119 | regulation of interleukin-2 production (GO:0032663) | 3.01585331 |
| 120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.01504656 |
| 121 | lymph node development (GO:0048535) | 3.01219119 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 3.00641218 |
| 123 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.00398364 |
| 124 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00283804 |
| 125 | B cell homeostasis (GO:0001782) | 2.99259916 |
| 126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98555927 |
| 127 | positive regulation of cell killing (GO:0031343) | 2.98327145 |
| 128 | translational termination (GO:0006415) | 2.97839134 |
| 129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96875673 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92939491 |
| 131 | response to host (GO:0075136) | 2.92939491 |
| 132 | response to host defenses (GO:0052200) | 2.92939491 |
| 133 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88590988 |
| 134 | neutrophil activation (GO:0042119) | 2.84462196 |
| 135 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82276922 |
| 136 | regulation of alpha-beta T cell activation (GO:0046634) | 2.81079513 |
| 137 | regulation of T cell mediated immunity (GO:0002709) | 2.80790914 |
| 138 | defense response to protozoan (GO:0042832) | 2.80730465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.73830928 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.53076368 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18962535 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.90915410 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.51812114 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.40775205 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.28569144 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.27601613 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.26545110 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.25630998 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22854469 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.20401895 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 3.03976694 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94737548 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.83267103 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69166754 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.63733479 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.61053174 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57372353 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56037123 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.53815043 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37896182 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36626716 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33765827 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10614120 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06091277 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05287626 |
| 28 | * MAF_26560356_Chip-Seq_TH2_Human | 2.02319956 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99025603 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98328459 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89813748 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88747537 |
| 33 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.87679501 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87109537 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87086825 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84869639 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84549407 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82974572 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82690094 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82013184 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74291194 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72890416 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72189166 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69256676 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65342583 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56388638 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53649557 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52814788 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44652963 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44119268 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40692191 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39263758 |
| 53 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38104659 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37219282 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36866973 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30212987 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29237093 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29004730 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26055402 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23600492 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19649611 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19601355 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18335719 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16317755 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16188886 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16011384 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15955671 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15742894 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14048045 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11916311 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11098986 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11005435 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10603824 |
| 74 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08556746 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06310295 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05684320 |
| 77 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.03968825 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03783217 |
| 79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02009450 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01696816 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99642363 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97528853 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95869927 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95100112 |
| 85 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93064268 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92231951 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92153425 |
| 88 | P300_27268052_Chip-Seq_Bcells_Human | 0.91810760 |
| 89 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91131488 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 0.91048142 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90885319 |
| 92 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90825069 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90752373 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90528881 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90306564 |
| 96 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89650512 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89295750 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89155012 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88555979 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87769036 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87438453 |
| 102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86291020 |
| 103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85975457 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85483987 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84582753 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82822613 |
| 107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81144544 |
| 108 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.79927186 |
| 109 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.77070393 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.76634737 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75256259 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.73584734 |
| 113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72481654 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70759654 |
| 115 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.70401336 |
| 116 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67951302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.55405446 |
| 2 | MP0005671_abnormal_response_to | 4.52353535 |
| 3 | MP0000685_abnormal_immune_system | 3.80103527 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.66729935 |
| 5 | MP0001800_abnormal_humoral_immune | 3.33993361 |
| 6 | MP0005387_immune_system_phenotype | 3.07690226 |
| 7 | MP0001790_abnormal_immune_system | 3.07690226 |
| 8 | * MP0002420_abnormal_adaptive_immunity | 2.92208890 |
| 9 | * MP0002398_abnormal_bone_marrow | 2.92072858 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.91581728 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.88748603 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.88273376 |
| 13 | * MP0001819_abnormal_immune_cell | 2.87365549 |
| 14 | MP0009785_altered_susceptibility_to | 2.85370791 |
| 15 | * MP0002723_abnormal_immune_serum | 2.84121949 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.77128719 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.72981268 |
| 18 | MP0001873_stomach_inflammation | 2.66417043 |
| 19 | MP0000703_abnormal_thymus_morphology | 2.55623948 |
| 20 | * MP0000716_abnormal_immune_system | 2.52378314 |
| 21 | * MP0005025_abnormal_response_to | 2.50213098 |
| 22 | MP0002405_respiratory_system_inflammati | 2.45434936 |
| 23 | MP0002722_abnormal_immune_system | 2.43282959 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.38916922 |
| 25 | MP0003724_increased_susceptibility_to | 2.37516969 |
| 26 | MP0003436_decreased_susceptibility_to | 2.37055092 |
| 27 | MP0002006_tumorigenesis | 2.29134403 |
| 28 | MP0003866_abnormal_defecation | 2.23870396 |
| 29 | MP0006082_CNS_inflammation | 2.19611659 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.19181109 |
| 31 | * MP0002429_abnormal_blood_cell | 2.10126794 |
| 32 | MP0004947_skin_inflammation | 2.03967795 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.98292291 |
| 34 | MP0002419_abnormal_innate_immunity | 1.94456535 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.90051877 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.88576690 |
| 37 | MP0002933_joint_inflammation | 1.88140370 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.84932937 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.71522710 |
| 40 | MP0001853_heart_inflammation | 1.66477803 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.56436582 |
| 42 | MP0004510_myositis | 1.55992028 |
| 43 | MP0003303_peritoneal_inflammation | 1.51786670 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.39779612 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.39779612 |
| 46 | MP0000858_altered_metastatic_potential | 1.35677258 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.33186966 |
| 48 | MP0000490_abnormal_crypts_of | 1.33183035 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.32672267 |
| 50 | MP0005310_abnormal_salivary_gland | 1.22379792 |
| 51 | MP0008260_abnormal_autophagy | 1.21229509 |
| 52 | MP0008469_abnormal_protein_level | 1.20645946 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.19067536 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.10780458 |
| 55 | MP0004381_abnormal_hair_follicle | 1.08285170 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.05394572 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.04446392 |
| 58 | MP0001851_eye_inflammation | 1.03290666 |
| 59 | MP0003448_altered_tumor_morphology | 1.01382321 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.00417447 |
| 61 | MP0005451_abnormal_body_composition | 0.95929612 |
| 62 | MP0005174_abnormal_tail_pigmentation | 0.95629116 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 0.93786350 |
| 64 | MP0002009_preneoplasia | 0.93074323 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.92091046 |
| 66 | MP0002132_abnormal_respiratory_system | 0.90604410 |
| 67 | MP0009840_abnormal_foam_cell | 0.87820454 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.87206322 |
| 69 | MP0008057_abnormal_DNA_replication | 0.85288619 |
| 70 | MP0009278_abnormal_bone_marrow | 0.85052245 |
| 71 | MP0005023_abnormal_wound_healing | 0.84880408 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.83945904 |
| 73 | MP0002254_reproductive_system_inflammat | 0.83782038 |
| 74 | MP0003828_pulmonary_edema | 0.82679229 |
| 75 | MP0003077_abnormal_cell_cycle | 0.79966284 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.78187957 |
| 77 | MP0009763_increased_sensitivity_to | 0.74149686 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.70226776 |
| 79 | MP0009764_decreased_sensitivity_to | 0.67460905 |
| 80 | MP0000477_abnormal_intestine_morphology | 0.66678262 |
| 81 | MP0003045_fibrosis | 0.66243074 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.65480834 |
| 83 | MP0000604_amyloidosis | 0.65356903 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.62216362 |
| 85 | MP0005390_skeleton_phenotype | 0.62146975 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.61785894 |
| 87 | MP0004883_abnormal_blood_vessel | 0.61146300 |
| 88 | MP0003075_altered_response_to | 0.61113462 |
| 89 | MP0001663_abnormal_digestive_system | 0.58815744 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.55962168 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.55229396 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.54972382 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 0.54879093 |
| 94 | MP0008058_abnormal_DNA_repair | 0.54193790 |
| 95 | MP0000313_abnormal_cell_death | 0.54109033 |
| 96 | MP0000609_abnormal_liver_physiology | 0.53182439 |
| 97 | MP0010094_abnormal_chromosome_stability | 0.52466393 |
| 98 | MP0001191_abnormal_skin_condition | 0.51289645 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.50991823 |
| 100 | MP0003795_abnormal_bone_structure | 0.50889747 |
| 101 | MP0002163_abnormal_gland_morphology | 0.50755626 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.50492367 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.50485096 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.50206536 |
| 105 | MP0006054_spinal_hemorrhage | 0.48276483 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.47307787 |
| 107 | MP0008874_decreased_physiological_sensi | 0.47213289 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.46946453 |
| 109 | MP0000249_abnormal_blood_vessel | 0.46609099 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.45575852 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.45526425 |
| 112 | MP0008873_increased_physiological_sensi | 0.44217497 |
| 113 | MP0000598_abnormal_liver_morphology | 0.43236589 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.43105457 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.40992152 |
| 116 | MP0000343_altered_response_to | 0.40106031 |
| 117 | MP0002083_premature_death | 0.37181751 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.36362721 |
| 119 | MP0001243_abnormal_dermal_layer | 0.35376651 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.34398505 |
| 121 | MP0000367_abnormal_coat/_hair | 0.34380316 |
| 122 | MP0009379_abnormal_foot_pigmentation | 0.34171852 |
| 123 | MP0005166_decreased_susceptibility_to | 0.34116740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.95505102 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.64366752 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.67527903 |
| 4 | Recurrent bronchitis (HP:0002837) | 5.35463019 |
| 5 | Abnormality of T cells (HP:0002843) | 5.33578817 |
| 6 | IgM deficiency (HP:0002850) | 5.03138365 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.98681697 |
| 8 | Chronic otitis media (HP:0000389) | 4.81596654 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.73178042 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.52953150 |
| 11 | Nasal polyposis (HP:0100582) | 4.44837091 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.43773865 |
| 13 | Stomatitis (HP:0010280) | 4.43234086 |
| 14 | Recurrent viral infections (HP:0004429) | 4.40329348 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 4.39235887 |
| 16 | Myositis (HP:0100614) | 4.36178058 |
| 17 | IgG deficiency (HP:0004315) | 4.32525935 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.09889011 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 4.09889011 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 4.00507392 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.90789458 |
| 22 | Pustule (HP:0200039) | 3.83181330 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.81930117 |
| 24 | Lymphopenia (HP:0001888) | 3.80065784 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.73910878 |
| 26 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.64322746 |
| 27 | Chronic diarrhea (HP:0002028) | 3.62988054 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.55560367 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.50988323 |
| 30 | Abnormality of eosinophils (HP:0001879) | 3.43681925 |
| 31 | Thyroiditis (HP:0100646) | 3.43238279 |
| 32 | Thrombocytosis (HP:0001894) | 3.40381114 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.33885107 |
| 34 | B lymphocytopenia (HP:0010976) | 3.30854951 |
| 35 | Abnormality of B cell number (HP:0010975) | 3.30854951 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21643010 |
| 37 | Leukocytosis (HP:0001974) | 3.17722576 |
| 38 | Meningitis (HP:0001287) | 3.15132804 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.14430146 |
| 40 | Spontaneous hematomas (HP:0007420) | 3.12125677 |
| 41 | Joint swelling (HP:0001386) | 3.06496752 |
| 42 | Recurrent sinusitis (HP:0011108) | 3.05756509 |
| 43 | Increased IgM level (HP:0003496) | 3.04555394 |
| 44 | Vasculitis (HP:0002633) | 3.03424906 |
| 45 | Hypoplasia of the thymus (HP:0000778) | 3.00850507 |
| 46 | Bronchitis (HP:0012387) | 3.00208808 |
| 47 | Eosinophilia (HP:0001880) | 2.94493300 |
| 48 | Orchitis (HP:0100796) | 2.93857618 |
| 49 | Urticaria (HP:0001025) | 2.92054711 |
| 50 | Optic neuritis (HP:0100653) | 2.90654757 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.90654757 |
| 52 | Basal cell carcinoma (HP:0002671) | 2.90482725 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.90129412 |
| 54 | Hemoptysis (HP:0002105) | 2.87110519 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.85357763 |
| 56 | Recurrent abscess formation (HP:0002722) | 2.83961502 |
| 57 | Granulocytopenia (HP:0001913) | 2.81783711 |
| 58 | IgA deficiency (HP:0002720) | 2.81542525 |
| 59 | Lymphoma (HP:0002665) | 2.80244083 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.78906636 |
| 61 | Encephalitis (HP:0002383) | 2.76295937 |
| 62 | Epistaxis (HP:0000421) | 2.75190526 |
| 63 | Hypochromic anemia (HP:0001931) | 2.74097358 |
| 64 | Recurrent skin infections (HP:0001581) | 2.72071175 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.69438110 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.65743656 |
| 67 | Chronic sinusitis (HP:0011109) | 2.58848472 |
| 68 | Papilloma (HP:0012740) | 2.51752665 |
| 69 | Verrucae (HP:0200043) | 2.51752665 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.49706102 |
| 71 | Petechiae (HP:0000967) | 2.47229922 |
| 72 | Anorexia (HP:0002039) | 2.47033241 |
| 73 | Gingivitis (HP:0000230) | 2.46520272 |
| 74 | Increased IgE level (HP:0003212) | 2.41665143 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.40830733 |
| 76 | Obstructive lung disease (HP:0006536) | 2.40234371 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40234371 |
| 78 | Chest pain (HP:0100749) | 2.35422452 |
| 79 | Arterial thrombosis (HP:0004420) | 2.31447161 |
| 80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.29444121 |
| 81 | Stomach cancer (HP:0012126) | 2.28397730 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26783198 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26783198 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26783198 |
| 85 | Osteomyelitis (HP:0002754) | 2.25831571 |
| 86 | Recurrent otitis media (HP:0000403) | 2.24962918 |
| 87 | Abnormal number of erythroid precursors (HP:0012131) | 2.23967662 |
| 88 | Gastrointestinal stroma tumor (HP:0100723) | 2.23730094 |
| 89 | Pulmonary embolism (HP:0002204) | 2.22604998 |
| 90 | Gingival bleeding (HP:0000225) | 2.21048450 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.20052841 |
| 92 | Fatigue (HP:0012378) | 2.18881874 |
| 93 | Poikiloderma (HP:0001029) | 2.16769925 |
| 94 | Abnormality of the prostate (HP:0008775) | 2.15863180 |
| 95 | Microcytic anemia (HP:0001935) | 2.14532356 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.10102944 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.09860271 |
| 98 | Keratitis (HP:0000491) | 2.09490843 |
| 99 | Colitis (HP:0002583) | 2.06437181 |
| 100 | Gangrene (HP:0100758) | 2.04711367 |
| 101 | Cheilitis (HP:0100825) | 2.03488937 |
| 102 | Amaurosis fugax (HP:0100576) | 2.03460145 |
| 103 | Increased serum ferritin (HP:0003281) | 2.02488780 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 2.01854696 |
| 105 | Increased cerebral lipofuscin (HP:0011813) | 2.01604517 |
| 106 | Skin rash (HP:0000988) | 2.01410839 |
| 107 | Sepsis (HP:0100806) | 2.00811964 |
| 108 | Emphysema (HP:0002097) | 2.00643111 |
| 109 | Cellulitis (HP:0100658) | 1.99632460 |
| 110 | Aplastic anemia (HP:0001915) | 1.99271107 |
| 111 | Episodic fever (HP:0001954) | 1.98760459 |
| 112 | Keratoconjunctivitis (HP:0001096) | 1.98024701 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.96524980 |
| 114 | Abnormality of the pleura (HP:0002103) | 1.95772443 |
| 115 | Acute hepatic failure (HP:0006554) | 1.94661071 |
| 116 | Abnormal platelet function (HP:0011869) | 1.94125095 |
| 117 | Impaired platelet aggregation (HP:0003540) | 1.94125095 |
| 118 | Glomerulopathy (HP:0100820) | 1.93461763 |
| 119 | Hepatitis (HP:0012115) | 1.92990456 |
| 120 | Viral hepatitis (HP:0006562) | 1.91753888 |
| 121 | Reticulocytopenia (HP:0001896) | 1.90432638 |
| 122 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.88093332 |
| 123 | Skin ulcer (HP:0200042) | 1.87564429 |
| 124 | Ureteral stenosis (HP:0000071) | 1.87124484 |
| 125 | Bronchiectasis (HP:0002110) | 1.83300120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.02320013 |
| 2 | TXK | 5.78849493 |
| 3 | RIPK4 | 3.66884085 |
| 4 | JAK3 | 3.16719751 |
| 5 | ZAP70 | 3.11672729 |
| 6 | ITK | 2.97392053 |
| 7 | FGFR4 | 2.93489150 |
| 8 | IKBKE | 2.76683043 |
| 9 | TYK2 | 2.70000808 |
| 10 | STK10 | 2.51724180 |
| 11 | PRPF4B | 2.46568165 |
| 12 | GRK6 | 2.18793787 |
| 13 | NLK | 2.07785317 |
| 14 | NME2 | 1.99538697 |
| 15 | JAK1 | 1.99086861 |
| 16 | LCK | 1.97399035 |
| 17 | TEC | 1.92939612 |
| 18 | FGFR3 | 1.82128832 |
| 19 | KIT | 1.80431885 |
| 20 | TBK1 | 1.76500300 |
| 21 | BTK | 1.76113286 |
| 22 | KDR | 1.75956836 |
| 23 | MAP3K14 | 1.69019886 |
| 24 | SYK | 1.64011038 |
| 25 | MAP3K13 | 1.60064622 |
| 26 | MAP3K11 | 1.56451764 |
| 27 | EEF2K | 1.50764579 |
| 28 | CSK | 1.44454260 |
| 29 | HCK | 1.38097067 |
| 30 | MAP3K10 | 1.33309541 |
| 31 | TGFBR2 | 1.28620379 |
| 32 | LRRK2 | 1.25306501 |
| 33 | IRAK4 | 1.22881952 |
| 34 | BLK | 1.22661935 |
| 35 | SIK2 | 1.18137069 |
| 36 | IKBKB | 1.18072554 |
| 37 | SMG1 | 1.16719322 |
| 38 | TLK1 | 1.16545441 |
| 39 | MAP3K3 | 1.13388464 |
| 40 | PRKCQ | 1.10802982 |
| 41 | PKN2 | 1.09637321 |
| 42 | TESK2 | 1.08853431 |
| 43 | MARK3 | 1.05359145 |
| 44 | MST4 | 1.03252762 |
| 45 | TNK2 | 1.03132170 |
| 46 | FGR | 1.01605437 |
| 47 | TGFBR1 | 1.00239090 |
| 48 | PRKCH | 0.99617539 |
| 49 | MAP3K1 | 0.96508004 |
| 50 | PIM1 | 0.95638893 |
| 51 | BMPR2 | 0.95341547 |
| 52 | CLK1 | 0.93909052 |
| 53 | CSF1R | 0.93341056 |
| 54 | LYN | 0.90725846 |
| 55 | FES | 0.90170341 |
| 56 | TAOK2 | 0.89898902 |
| 57 | SIK3 | 0.88320954 |
| 58 | MAP3K12 | 0.86767897 |
| 59 | JAK2 | 0.84764040 |
| 60 | RPS6KA4 | 0.82239296 |
| 61 | FLT3 | 0.79083941 |
| 62 | MAP2K2 | 0.78671915 |
| 63 | ERN1 | 0.78438606 |
| 64 | MATK | 0.76071404 |
| 65 | MAP3K7 | 0.75598366 |
| 66 | MAP2K3 | 0.74600013 |
| 67 | CHUK | 0.68512684 |
| 68 | CDK4 | 0.59993464 |
| 69 | TRIB3 | 0.59755181 |
| 70 | CAMKK2 | 0.59018790 |
| 71 | PASK | 0.58832373 |
| 72 | IRAK3 | 0.49906939 |
| 73 | CAMKK1 | 0.49390813 |
| 74 | MAP2K6 | 0.49114494 |
| 75 | PIK3CG | 0.48150111 |
| 76 | MARK2 | 0.48032771 |
| 77 | SRPK1 | 0.47426831 |
| 78 | HIPK2 | 0.46652312 |
| 79 | PRKD2 | 0.45217561 |
| 80 | MAPKAPK2 | 0.44314937 |
| 81 | PIM2 | 0.44182236 |
| 82 | PDGFRB | 0.43959721 |
| 83 | MAPK11 | 0.43583122 |
| 84 | PDK1 | 0.43479401 |
| 85 | MAPK7 | 0.40763218 |
| 86 | STK4 | 0.40453878 |
| 87 | ACVR1B | 0.40044524 |
| 88 | NEK9 | 0.39707321 |
| 89 | RPS6KL1 | 0.38834717 |
| 90 | RPS6KC1 | 0.38834717 |
| 91 | MAP3K8 | 0.37842926 |
| 92 | EPHA3 | 0.37656120 |
| 93 | TYRO3 | 0.37491733 |
| 94 | PDPK1 | 0.37079352 |
| 95 | IGF1R | 0.35620005 |
| 96 | PTK6 | 0.35254521 |
| 97 | FYN | 0.34790642 |
| 98 | INSR | 0.34254749 |
| 99 | TTN | 0.33537787 |
| 100 | IRAK1 | 0.33049217 |
| 101 | GRK7 | 0.32624051 |
| 102 | MAPK4 | 0.31340600 |
| 103 | SCYL2 | 0.30815528 |
| 104 | MAPK12 | 0.30520442 |
| 105 | TAOK1 | 0.30490116 |
| 106 | BCKDK | 0.30396048 |
| 107 | RPS6KB2 | 0.30222242 |
| 108 | EPHB1 | 0.29248337 |
| 109 | MAPK3 | 0.27731586 |
| 110 | RAF1 | 0.27079907 |
| 111 | MAP3K5 | 0.26967729 |
| 112 | TAOK3 | 0.26941375 |
| 113 | RPS6KA5 | 0.26753759 |
| 114 | CDK12 | 0.26251394 |
| 115 | RPS6KA6 | 0.25774498 |
| 116 | BRD4 | 0.25522457 |
| 117 | CDK9 | 0.25322471 |
| 118 | CDC42BPA | 0.24504524 |
| 119 | SIK1 | 0.24468169 |
| 120 | RPS6KA1 | 0.24158885 |
| 121 | CDK6 | 0.24113679 |
| 122 | MELK | 0.23842864 |
| 123 | KSR2 | 0.23496602 |
| 124 | ABL1 | 0.23192885 |
| 125 | ALK | 0.22651528 |
| 126 | TRPM7 | 0.22016736 |
| 127 | ATR | 0.21849255 |
| 128 | YES1 | 0.20118239 |
| 129 | TNIK | 0.19761382 |
| 130 | FGFR1 | 0.18577013 |
| 131 | STK24 | 0.18536084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.97714176 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.66787328 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.12268820 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.99657621 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.93953149 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.85697183 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64382669 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.58221843 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43167129 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.40324213 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12715794 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.09838999 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06199816 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99037448 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86812715 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80868044 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.78241183 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77908468 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77146292 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74223294 |
| 21 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71627337 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34133222 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31052969 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.29247980 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28329804 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28108183 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26315854 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.25207609 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24160216 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23964932 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23647508 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.18774880 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18076736 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16291667 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.14614353 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12565340 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.10842752 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06976179 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.06777380 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.06247712 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.02898231 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02240585 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.99423645 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95797797 |
| 45 | Mismatch repair_Homo sapiens_hsa03430 | 0.94942743 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94135249 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 0.92708493 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92314805 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.89464001 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87838732 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.86580736 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86338915 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.80989312 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79399679 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.78984993 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78070087 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77659595 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77076720 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75396990 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74060151 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71915611 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71062460 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71008713 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.70423731 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67106016 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65703809 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65362234 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.65133585 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.64936743 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.60817732 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60582033 |
| 72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58850374 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56256624 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.52225812 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51216463 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50201142 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49545825 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49466089 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49423087 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47473478 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47318320 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.46989580 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46889047 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43870996 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43100890 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40981933 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39945653 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39540573 |
| 89 | RNA polymerase_Homo sapiens_hsa03020 | 0.35737335 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35625739 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35169130 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34387836 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34256098 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.34215133 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34044470 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30283271 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.30072759 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29854948 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29746101 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.27861397 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27190677 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.26433391 |
| 103 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.26251022 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25838046 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25449541 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24141043 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24133719 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23593632 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23510794 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23108919 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22465537 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21814994 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21398413 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20907255 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20786511 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20477591 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.19559997 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19021183 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17712728 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.17149690 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14168242 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13779836 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.10681880 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09008195 |

